Welcome

to Galapagos


Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action.

Our ambition is to become a leading global biopharmaceutical company, focused on the discovery, development and commercialization of innovative medicines that will improve people's lives.

Want to know more about unmet needs in RA, JAK-STAT, treatment guidelines, or clinical outcomes?
What causes JAK-STAT signalling dysregulation and inflammatory response?

Therapy Areas

Events

  • {{m.monthYear}}
No events found.
{{calendar.eventCategory}}

{{ calendar.eventHourMin}} ({{ calendar.timezone}})

{{calendar.eventName}}

{{calendar.eventDescription}}

  • {{page}}
No events found.
{{calendar.eventCategory}}

{{ calendar.eventHourMin}} ({{ calendar.timezone}})

{{calendar.eventName}}

{{calendar.eventDescription}}

  • {{page}}

About us

Our Research

Galapagos’ core research areas are inflammatory, fibrotic, and kidney diseases, where our clinical activity is focused across several indications.